10 
Dr. John G. Adams, representing the Pharmaceutical Manufac- 
turers Association, responded as follows to the question of how more 
stringent State or local regulations on recombinant DNA research 
might affect his industry : 
. . . if a local community posed a ban or severe restrictions, 
standards higher than those which ultimately would be 
promulgated in guidelines, I think in order to continue the 
research and continue to endeavor they might consider a 
relocation of their research facility. 
Particularly since recombinant DNA research appears to have consid- 
erable potential for utility in many fields and hence may result in 
new technologies with marked economic impact, the Subcommittee 
is concerned that this relocation may take place on an international 
level. 
This concern is not merely with industrial relocation, but also with 
the U.S. balance of trade generally. Further, it is a situation which 
raises concern beyond industrial research to academic research. Any 
significant U.S. lag in genetic technolQgy, for whatever reasons it may 
occur, could result in diminished power and prestige for this nation on 
the international scene. Such a possibility must not be overlooked as 
considerations for dealing with the recombinant DNA research 
issue go forward. 
[Appendix B — 61] 
